Elayntra
40 mg
Made in Germany · GMP Certified
SCIENCE FOR A HEALTHIER TOMORROW
Elayntra™ Retatrutide Injectable Kit
A precision subcutaneous pen kit featuring Retatrutide — a triple agonist of GLP-1, GIP and Glucagon receptors — crafted for clarity, purity and controlled use under professional guidance.
Triple agonist
GLP-1 · GIP · Glucagon receptor pathways
Triple Agonist
Targets GLP-1, GIP & glucagon receptors in one molecule.
Pen Precision
10 mg pen with dose window, safety lock & clear dial.
GMP Germany
Manufactured by Elayntra Healthcare under GMP standards.
Complete Kit
Pen, 12 needles & illustrated instruction booklet.
Elayntra Healthcare
Science-forward peptide innovation
Elayntra Healthcare is a German peptide and research brand built around clarity, purity and clinical seriousness. We design advanced injectable presentations — from multi-receptor agonist kits to a focused research catalogue — under GMP discipline and Made-in-Germany manufacturing. Our promise is simple: science for a healthier tomorrow, always framed for informed professional guidance where the law allows.
The Kit
Everything arranged for careful, guided use
From carton to pen to needle tips — Elayntra is designed as a complete injectable kit with packaging that puts dosing clarity and safety first.
Carton contents at a glance
- ✓1 pen of 4 × 10 mg dose — labeled Elayntra 10 mg, for subcutaneous use
- ✓12 disposable needles — individually capped for single use
- ✓1 instruction book — preparation, dose selection, injection steps & disposal
- ✓40 mg carton context — each full dose contains 10 mg; total 40 mg per kit presentation
The Range
Elayntra™ research formulations
A focused catalogue of sealed research presentations — manufactured under GMP standards in Germany. Laboratory R&D use only; not for human consumption.
40 mg
Elayntra™ Retatrutide
20 mg
Elayntra™ Retatrutide
70 mg
Elayntra™ Glow
1,000 mg
Elayntra™ NAD+
10 i.u.
Elayntra™ HGH
200 mg/mL
Elayntra™ Testosterone
Why Elayntra
Science-led healthcare innovation
We combine peptide science, German manufacturing discipline and patient-facing kit design — without overstating what only a clinician can decide.
Mechanism-first
Retatrutide is described as a triple agonist of GLP-1, GIP and glucagon receptors. Explore the pathways on our Science page — without invented trial claims.
Quality systems
GMP-certified manufacturing by Elayntra Healthcare in Germany, with packaging that documents ingredients, pH range and storage rules clearly.
Guided use only
Subcutaneous administration under a qualified healthcare professional where legally permitted. Not medical advice. No online checkout on this site.
Reviews
What professionals are saying
Feedback from clinics, laboratories and practitioners on Elayntra™ packaging, documentation and guided professional use.
Reviews describe individual experiences with kit presentation and service. They are not clinical trial results or medical advice. Elayntra™ products are for use only under qualified healthcare professional guidance where legally permitted.
Ready to learn more?
Speak with our support or sales teams about Elayntra™ availability, documentation and professional enquiries.
Contact ElayntraResearch catalogue
Products
Precision research formulations — peptides, NAD+, and HGH presentations — sealed, documented and manufactured under GMP standards in Germany.
40 mg
Elayntra™ Tirzepatide 40 mg
Dual agonist research formulation in a sealed pre-filled device for controlled laboratory studies.
40 mg
Elayntra™ Retatrutide 40 mg
Triple agonist research presentation for GLP-1, GIP and glucagon pathway studies.
20 mg
Elayntra™ Retatrutide 20 mg
Compact 20 mg Retatrutide research device for precision laboratory workflows.
70 mg
Elayntra™ Glow 70 mg
Multi-peptide research blend in a sealed device for laboratory formulation studies.
40 mg
Elayntra™ BPC-157 & TB-500 40 mg
Combined BPC-157 and TB-500 research formulation for controlled laboratory use.
1,000 mg
Elayntra™ NAD+ 1,000 mg
High-strength NAD+ research material for in-vitro and laboratory analysis.
10 i.u.
Elayntra™ HGH 10 i.u.
Human growth hormone (somatropin) research vial for controlled laboratory studies.
200 mg/mL
Elayntra™ Testosterone 10 ml
Sterile multi-dose testosterone research presentation, 10 ml vial at 200 mg/mL.
Professional & laboratory enquiries
Request documentation, availability or batch information for Elayntra™ research formulations.
Contact ElayntraElayntra™ Retatrutide
Injectable kit overview
A complete subcutaneous pen presentation: precision pen, needles and illustrated guidance — aligned with information printed on the Elayntra carton.
What is in the box
As stated on packaging: this box contains 1 pen of 4 × 10 mg dose, 12 disposable needles, and 1 instruction book.
- 1Elayntra 10 mg pen — dose knob, dose window, pen body, safety lock, pen cap; labeled for subcutaneous use
- 212 injection needles — with protective caps for single-use attachment
- 3Instruction booklet — preparation, usage, dose selection, injection steps, safety, storage & disposal
- 4Illustrated lid guide — numbered steps and labeled pen diagram inside the presentation tray lid
From the carton
Dosing & composition notes
The following reflects labeling on the Elayntra product packaging. Always follow the package insert and your clinician’s instructions.
| Active description | Retatrutide — triple agonist of GLP-1, GIP and Glucagon receptors |
|---|---|
| Dose per full delivery | Each full dose contains 10 mg |
| Carton total | Total of 40 mg (4 × 10 mg context) |
| Route | For subcutaneous use only |
| Reconstituted pH | 6.5 – 7.5 |
Dosing caution
Do not increase your weekly dose unless recommended by a healthcare professional. Read the package insert before use.
Ingredients (as listed)
Contains sodium chloride, sodium citrate, disodium hydrogen phosphate, and bacteriostatic water. Hydrochloric acid and/or sodium hydroxide may have been used to adjust pH.
If you experience severe gastrointestinal issues or typical side effects such as nausea, vomiting, diarrhea, constipation, abdominal discomfort, weakness, or dizziness, consult a healthcare professional.
Handling
Storage & in-use life
Protect potency and safety by following the storage rules printed on the carton.
Keep refrigerated
Store cold. Do not freeze. Keep the pen in the carton to protect from light.
12-week in-use window
Discard the pen 12 weeks after first use, even if medication remains.
Child safety
Keep out of the sight and reach of children at all times.
Professional guidance required
Elayntra™ is presented for use under a qualified healthcare professional where legally permitted. This page summarises packaging information and is not a substitute for the instruction booklet, package insert, or clinical advice. This website does not provide e-commerce checkout.
Questions about the kit?
Our support team can help with documentation requests and professional enquiries.
Contact support
40 mg
Elayntra™ Tirzepatide 40 mg
£100 GBP
Elayntra™ Tirzepatide 40 mg is a dual GLP-1 / GIP receptor agonist research formulation, supplied in a sealed pre-filled device for controlled laboratory R&D. Designed to support compound stability analysis, formulation studies and delivery-mechanism evaluation under GMP-aligned handling practices.
Specifications
| Compound | Tirzepatide |
|---|---|
| Strength | 40 mg |
| Presentation | Pre-filled research device, sealed |
| Use | Laboratory R&D only |
| Manufacture | Elayntra Healthcare · Germany · GMP |
40 mg
Elayntra™ Retatrutide 40 mg
£160 GBP
Elayntra™ Retatrutide 40 mg is a triple agonist research formulation engaging GLP-1, GIP and glucagon receptor pathways. Supplied in a sealed pre-filled device for controlled laboratory R&D — supporting stability, formulation and delivery evaluation. For the complete injectable kit overview, see our Retatrutide kit deep-dive.
Specifications
| Compound | Retatrutide |
|---|---|
| Strength | 40 mg |
| Mechanism | Triple agonist — GLP-1 · GIP · Glucagon |
| Presentation | Pre-filled research device, sealed |
| Use | Laboratory R&D only |
| Manufacture | Elayntra Healthcare · Germany · GMP |
Looking for the complete injectable kit? View the Elayntra™ Retatrutide kit deep-dive →
20 mg
Elayntra™ Retatrutide 20 mg
£100 GBP
Elayntra™ Retatrutide 20 mg offers a lower-strength triple agonist research presentation for laboratories requiring finer quantity control. Sealed pre-filled format supports stability analysis and delivery-mechanism evaluation. Explore the full injectable kit presentation on our Retatrutide kit page.
Specifications
| Compound | Retatrutide |
|---|---|
| Strength | 20 mg |
| Mechanism | Triple agonist — GLP-1 · GIP · Glucagon |
| Presentation | Pre-filled research device, sealed |
| Use | Laboratory R&D only |
| Manufacture | Elayntra Healthcare · Germany · GMP |
Looking for the complete injectable kit? View the Elayntra™ Retatrutide kit deep-dive →
70 mg
Elayntra™ Glow 70 mg
£100 GBP
Elayntra™ Glow 70 mg is a multi-peptide research formulation supplied in a sealed pre-filled device. Intended exclusively for controlled laboratory R&D — compound characterisation, stability work and delivery evaluation under disciplined GMP-aligned practices.
Specifications
| Compound | Glow multi-peptide research blend |
|---|---|
| Strength | 70 mg |
| Presentation | Pre-filled research device, sealed |
| Use | Laboratory R&D only |
| Manufacture | Elayntra Healthcare · Germany · GMP |
40 mg
Elayntra™ BPC-157 & TB-500 40 mg
£130 GBP
Elayntra™ BPC-157 & TB-500 40 mg combines two widely studied research peptides in a single sealed pre-filled device. Provided exclusively for controlled laboratory R&D applications — stability analysis, formulation studies and delivery-mechanism evaluation.
Specifications
| Compound | BPC-157 & TB-500 |
|---|---|
| Strength | 40 mg (combined) |
| Presentation | Pre-filled research device, sealed |
| Use | Laboratory R&D only |
| Manufacture | Elayntra Healthcare · Germany · GMP |
1,000 mg
Elayntra™ NAD+ 1,000 mg
£160 GBP
Elayntra™ NAD+ (Nicotinamide Adenine Dinucleotide) 1,000 mg is a high-strength research formulation for laboratory analysis and in-vitro studies. Supplied for controlled R&D applications only — never for human consumption.
Specifications
| Compound | NAD+ (Nicotinamide Adenine Dinucleotide) |
|---|---|
| Strength | 1,000 mg |
| Presentation | Research formulation, sealed |
| Use | Laboratory R&D / in-vitro only |
| Manufacture | Elayntra Healthcare · Germany · GMP |
10 i.u.
Elayntra™ HGH 10 i.u.
On request
Elayntra™ HGH (Human Growth Hormone / somatropin, rDNA origin) is supplied as a sealed research vial at 10 i.u. per vial for controlled laboratory R&D. Intended for compound characterisation, stability and formulation studies under GMP-aligned handling — not for human use.
Specifications
| Compound | Human Growth Hormone (somatropin, rDNA) |
|---|---|
| Strength | 10 i.u. / vial |
| Presentation | Sealed glass research vial |
| Use | Laboratory R&D only |
| Manufacture | Elayntra Healthcare · Germany · GMP |
200 mg/mL
Elayntra™ Testosterone 10 ml
On request
Elayntra™ Testosterone is a sterile multi-dose research presentation at 200 mg/mL in a 10 ml vial for controlled laboratory R&D. Supplied for analytical and formulation studies under GMP-aligned handling — not for human consumption or clinical use.
Specifications
| Compound | Testosterone (research grade) |
|---|---|
| Strength | 200 mg/mL |
| Volume | 10 ml sterile multi-dose vial |
| Presentation | Sealed glass research vials |
| Use | Laboratory R&D only |
| Manufacture | Elayntra Healthcare · Germany · GMP |
Mechanism overview
Triple agonist science
Elayntra™ presents Retatrutide as a triple agonist of GLP-1, GIP and Glucagon receptors. This page explains those pathways in plain language — without inventing trial statistics or outcome claims.
Three receptors · One molecule
Retatrutide triple agonist mechanism
Incretin and glucagon pathways help the body coordinate appetite signaling, insulin response and energy balance. A triple agonist is designed to engage all three receptor families.
GLP-1 receptor
Glucagon-like peptide-1 (GLP-1) receptors are part of the incretin system. Agonism at this receptor is associated in scientific literature with effects on insulin secretion in a glucose-dependent manner and on satiety-related signaling. Elayntra packaging identifies GLP-1 as one of the three targeted receptors.
GIP receptor
Glucose-dependent insulinotropic polypeptide (GIP) is the second major incretin hormone. Engaging GIP receptors complements GLP-1 pathway activity in multi-agonist peptide design. Packaging for Elayntra lists GIP alongside GLP-1 and glucagon.
Glucagon receptor
Glucagon receptor activity is involved in hepatic energy metabolism and energy expenditure pathways. Including glucagon receptor agonism is a defining feature of a “triple” agonist versus dual incretin approaches.
Educational scope
We describe receptor targets as labeled on Elayntra materials. We do not publish fabricated efficacy percentages, weight-loss averages, or trial endpoint numbers on this site. For clinical decision-making, rely on peer-reviewed literature, regulatory labeling where applicable, and a qualified healthcare professional.
Delivery context
Why a subcutaneous pen kit?
Peptide medicines of this class are commonly administered by subcutaneous injection. The Elayntra kit pairs a 10 mg pen (4 × 10 mg / 40 mg carton context) with disposable needles and a step-by-step instruction book so preparation, dose selection and injection technique can be reviewed carefully with a clinician.
Pen features highlighted in kit imagery include a dose window, dose knob, safety lock, pen cap and clearly labeled needle interface — supporting controlled, repeatable handling when used as directed.
See kit specifications
Responsible communication
What we will — and will not — claim
We share
- Receptor targets named on packaging (GLP-1, GIP, Glucagon)
- Route of administration (subcutaneous)
- Kit composition, storage and in-use discard window
- Manufacturing origin and GMP positioning
We avoid
- Invented clinical trial statistics or guarantees of outcome
- Self-diagnosis or self-prescribing encouragement
- Online purchase / checkout funnels on this website
- Substituting web copy for medical advice
Standards
Quality without compromise
Manufactured by Elayntra Healthcare in Germany, with GMP-certified positioning on packaging — because injectable peptide kits demand disciplined production and transparent labeling.
GMP Certified
Made in Germany
Elayntra Healthcare
Manufacturing
German craftsmanship meets GMP discipline
Every Elayntra carton carries the mark of origin: manufactured by Elayntra Healthcare, Made in Germany. Our quality story is grounded in controlled processes, batch identification on packaging, and clear composition disclosure — not marketing hyperbole.
GMP (Good Manufacturing Practice) certification is highlighted on product packaging as a signal of structured manufacturing controls for facilities producing medicinal and related healthcare products.
- Documented manufacturer identity on each carton
- Batch and expiry fields for traceability
- Ingredient list and pH range printed for transparency
- Storage and discard instructions to protect product integrity after opening
Purity & presentation
Clarity from factory to first use
Quality is not only what happens in the plant — it is also how the kit is organized for safe handling.
Formulation clarity
Packaging lists inactive components and the reconstituted pH window (6.5–7.5), so professionals know what to expect from the presentation.
Protected storage
Keep refrigerated, do not freeze, store in carton to protect from light, and discard 12 weeks after first use — integrity rules printed on the box.
Kit-level control
Molded tray, counted needles, labeled pen and illustrated instructions reduce ambiguity at the point of preparation and injection.
Our quality pillars
How we think about excellence
Process & people
Quality systems depend on trained teams, controlled environments and documented procedures. Elayntra Healthcare builds the Retatrutide kit presentation around those expectations — with German manufacturing as a cornerstone of brand trust.
Honest labeling
Warnings, side-effect guidance, dosing caution and child-safety statements appear on packaging for a reason. Our website echoes those messages rather than softening them for conversion.
Authenticity & professional channels
Source Elayntra™ only through legitimate, legally permitted channels. This website does not operate an online shop or checkout. For verification or distribution questions, contact support or sales.
Elayntra Healthcare
Welcome to Elayntra
A healthcare innovator rooted in Germany — advancing thoughtful peptide injectable presentations with a simple promise: science for a healthier tomorrow.
Who we are
Peptide innovation with clinical seriousness
At the intersection of molecular science and practical kit design, Elayntra Healthcare focuses on advanced peptide presentations that serve modern metabolic and wellness-oriented care pathways — always framed for use under qualified professional guidance where the law allows.
Our flagship Elayntra™ Retatrutide injectable kit brings together a precision 10 mg pen, disposable needles and clear instructional materials in a GMP-oriented, Made-in-Germany presentation.
We specialize in
- Injectable peptide kit design & packaging clarity
- Multi-receptor agonist presentations (GLP-1 / GIP / Glucagon)
- German manufacturing partnerships and GMP discipline
- Professional education without overstated claims
Mission
What drives Elayntra
Our mission is deliberate and human-centered.
Accessible clarity
Make sophisticated peptide science understandable — through honest labeling, illustrated instructions and responsible web education.
Harness peptides wisely
Support healthcare professionals with carefully presented products intended to fit structured, supervised care — not unsupervised self-experimentation.
Healthier tomorrows
Align every carton with our slogan: SCIENCE FOR A HEALTHIER TOMORROW — purity, process and patient-facing safety messaging first.
Commitment
Quality at the heart of everything
Quality is not a department; it is how Elayntra ships. From GMP-certified manufacturing marks to refrigeration and 12-week discard rules printed on the carton, we treat injectable kits with the seriousness they deserve.
We invest in formulation presentation, excipient transparency and kit ergonomics so that preparation and subcutaneous administration can be reviewed step by step with a clinician.
Explore quality standardsInnovation
Research mindset
We stay close to the evolving science of multi-agonist peptides — translating receptor biology into product storytelling that remains factual. We do not invent trial statistics for marketing pages.
- Mechanism education grounded in labeled receptor targets
- Formulation and handling guidance mirrored from packaging
- Continuous refinement of kit usability and documentation
- Partnership with professional channels, not direct-to-cart hype
Join the journey
Built for professionals & informed patients
Whether you are a clinician evaluating presentations or a patient learning about a prescribed pathway, Elayntra exists to communicate clearly — and to insist that real decisions happen with a qualified healthcare professional.
Important notice
Elayntra™ products are for use only under qualified healthcare professional guidance where legally permitted. This website provides information only and does not offer medical advice or online checkout.
Get in touch
We’re here to help
Contact Elayntra
Reach support or sales for documentation, professional enquiries and distribution questions. This site does not process orders or payments.
Manufacturer
Elayntra Healthcare
Made in Germany · GMP Certified
Web domains
elayntra.com
elayntra.eu
elayntra.uk
Official brand properties will point to this site experience.
No online checkout
Elayntra does not sell injectable kits through a cart on this website. Beware of unauthorized sellers. Contact us to verify legitimate channels.